Home  ›  If I Was Immunized in the 60 for Measles Can I Catch Them Again

If I Was Immunized in the 60 for Measles Can I Catch Them Again

Written By domingo, 24 de abril de 2022 Add Comment Edit

Vaccine used to prevent measles

Measles vaccine
Providing vaccinations to protect against disease after Typhoon Haiyan (11352296333).jpg

A kid is given a measles vaccine.
Vaccine description
Target Measles virus
Vaccine blazon Attenuated
Clinical data
AHFS/Drugs.com Monograph
MedlinePlus a601176
ATC code
  • J07BD01 (WHO)
Legal status
Legal status
  • United kingdom: POM (Prescription only)
  • United states: ℞-only
Identifiers
CAS Number
  • 1704515-59-2 check Y
ChemSpider
  • none
KEGG
  • D04866
☒ N check Y  (what is this?) (verify)

Measles vaccine protects against condign infected with measles.[1] Nearly all of those who practise not develop immunity after a unmarried dose develop it after a 2nd dose.[i] When rates of vaccination within a population are greater than 92%, outbreaks of measles typically no longer occur; however, they may occur again if rates of vaccination decrease.[1] The vaccine'due south effectiveness lasts many years.[1] Information technology is unclear if it becomes less effective over time.[1] The vaccine may too protect against measles if given within a couple of days afterward exposure to measles.[i]

The vaccine is generally safe, even for those infected by HIV.[1] [2] Most children do not experience any side effects;[3] those that do occur are normally mild, such equally fever, rash, hurting at the site of injection, and joint stiffness; and are short-lived.[one] [3] Anaphylaxis has been documented in about 3.five–10 cases per million doses.[1] Rates of Guillain–Barré syndrome, autism and inflammatory bowel affliction practise non appear to be increased by measles vaccination.[1]

The vaccine is available both past itself and in combinations such as the MMR vaccine (a combination with the rubella vaccine and mumps vaccine)[1] or the MMRV vaccine (a combination of MMR with the chickenpox vaccine).[4] [5] [half-dozen] The measles vaccine is equally effective for preventing measles in all formulations, but side effects vary for dissimilar combinations.[1] [7] The Globe Health Organization (WHO) recommends measles vaccine exist given at nine months of age in areas of the world where the illness is mutual, or at twelve months where the disease is non common.[1] Measles vaccine is based on a live but weakened strain of measles.[ane] It comes as a dried powder which is mixed with a specific liquid before being injected either just under the peel or into a muscle.[1] Verification that the vaccine was effective can exist determined past blood tests.[1]

The measles vaccine was offset introduced in 1963.[8] In that year, the Edmonston-B strain of measles virus was turned into a vaccine by John Enders and colleagues and licensed in the The states.[9] [10] In 1968, an improved and even weaker measles vaccine was adult past Maurice Hilleman and colleagues, and began to be distributed, becoming the only measles vaccine used in the United States since 1968.[9] [10] About 85% of children globally had received this vaccine as of 2013.[eleven] In 2015, at to the lowest degree 160 countries provided 2 doses in their routine immunization.[12] It is on the World Health Organization'south List of Essential Medicines.[13] As outbreaks easily occur in nether-vaccinated populations, not-prevalence of disease is seen as a exam of sufficient vaccination within a population.[xiv]

Medical uses [edit]

Measles cases 1938-1964 follow a highly variable epidemic pattern, with 150,000-850,000 cases per year. A sharp decline followed introduction of the vaccine in 1963, with fewer than 25,000 cases reported in 1968. Outbreaks around 1971 and 1977 gave 75,000 and 57,000 cases, respectively. Cases were stable at a few thousand per year until an outbreak of 28,000 in 1990. Cases declined from a few hundred per year in the early 1990s to a few dozen in the 2000s.

Measles cases reported in the United States earlier and later on introduction of the vaccine.

Measles cases reported in Canada before and afterward introduction of the vaccine. Betwixt 1959 and 1968 measles was not nationally reportable, hence at that place are no data are this flow.

Measles cases reported in England and Wales.

One dose is almost 93% constructive while 2 doses of the vaccine are about 97% effective at preventing measles.[2] Earlier the widespread use of the vaccine, measles was so common that infection was considered "as inevitable as death and taxes."[15] In the United States, reported cases of measles fell from 3 to iv million with 400 to 500 deaths to tens of thousands per yr following introduction of two measles vaccines in 1963 (both an inactivated and a alive attenuated vaccine (Edmonston B strain) were licensed for utilize, see chart at right).[two] [16] Increasing uptake of the vaccine following outbreaks in 1971 and 1977 brought this down to thousands of cases per yr in the 1980s. An outbreak of most 30,000 cases in 1990 led to a renewed push for vaccination and the addition of a 2d vaccine to the recommended schedule. No more than 220 cases were reported in whatsoever year from 1997 to 2013, and the disease was believed no longer endemic in the United states of america.[17] [18] [19] In 2014, 667 cases were reported.[20]

The benefit of measles vaccination in preventing illness, disability, and death have been well documented. Within the outset xx years of beingness licensed in the U.Southward., measles vaccination prevented an estimated 52 million cases of the disease, 17,400 cases of intellectual disability, and 5,200 deaths.[21] From 1999 to 2004 a strategy led by the WHO and UNICEF led to improvements in measles vaccination coverage that averted an estimated 1.4 meg measles deaths worldwide.[22] The vaccine for measles led to the near-complete emptying of the disease in the United states and other developed countries.[23] While the vaccine is made with a live virus which tin can crusade side effects, these are far fewer and less serious than the sickness and death acquired by measles itself; side effects ranging from rashes to, rarely, convulsions, occur in a small percentage of recipients.[24]

Measles is common worldwide. Although it was declared eliminated from the U.S. in 2000, high rates of vaccination and excellent advice with those who refuse vaccination are needed to prevent outbreaks and sustain the elimination of measles.[25] Of the 66 cases of measles reported in the U.South. in 2005, slightly over half were attributable to i unvaccinated teenager who became infected during a visit to Romania.[26] This private returned to a community with many unvaccinated children. The resulting outbreak infected 34 people, mostly children and about all unvaccinated; three of them were hospitalized. The public health response required making nigh v,000 phone calls as part of contact tracing, arranging and performing testing as needed, and arranging emergency vaccination for at-run a risk people who had had contact with this person.[25] Taxpayers and local healthcare organizations likely paid more than The states$167,000 in direct costs to incorporate this one outbreak.[25] A major epidemic was averted due to high rates of vaccination in the surrounding communities.[25]

The vaccine has not specific effects such as preventing respiratory infections, that may be greater than those of measles prevention lonely. These benefits are greater when the vaccine is given before one year of historic period. A high-titre vaccine resulted in worse outcomes in girls, and consequently is not recommended by the World Health Organization.[27]

Schedule [edit]

The Earth Wellness Arrangement (WHO) recommends two doses of vaccine for all children.[i] In countries with high risk of disease the first dose should be given around 9 months of historic period.[1] Otherwise it can be given at twelve months of historic period.[i] The second dose should be given at least one month later on the kickoff dose.[i] This is often done at age 15 to eighteen months.[1] Later ane dose at the historic period of nine months 85% are immune, while a dose at twelve months results in 95% immunity.[8]

In the United States, the Centers for Affliction Control and Prevention (CDC) recommends that children anile six to eleven months traveling outside the United States receive their first dose of MMR vaccine earlier departure[28] then receive two more doses; one at 12–15 months (12 months for children in high-run a risk areas) and the second as early as iv weeks later on.[29] Otherwise the first dose is typically given at 12–15 months and the second at iv–6 years.[29]

In the United kingdom of great britain and northern ireland, the National Wellness Service (NHS) recommendation is for a start dose at around thirteen months of age and the 2d at three years and 4 months old.[xxx] [31]

In Canada, Wellness Canada recommends that children traveling outside North America should receive an MMR vaccine if they are aged half dozen to 12 months. However, after the child is 12 months old they should receive two boosted doses to ensure long-lasting protection.[32]

Adverse effects [edit]

Adverse furnishings associated with the MMR vaccine include fever, rash, injection site hurting and, in rare cases, reddish or purple discolorations on the skin known as thrombocytopenic purpura, or seizures related to fever (febrile seizure).[33] [34]

Numerous studies accept found no relationship between MMR vaccine and autism.[35] [36] [37] [34]

Contraindications [edit]

Information technology is inadvisable for some people to receive the measles or MMR vaccine, including cases of:

  • Pregnancy: MMR vaccine and its components should not be given to meaning women.[38] Women of childbearing age should check with their doctor about getting vaccinated prior to getting meaning.[6]
  • HIV-infected children, who may receive measles vaccines if their CD4+ lymphocyte count is greater than fifteen%.[39]
  • Weakened immune arrangement due to HIV/AIDS or sure medical treatments[6]
  • Having a parent or sibling with a history of immune problems [6]
  • Condition that makes a patient bruise or drain easily[vi]
  • Recent transfusion of blood or blood products[half dozen]
  • Tuberculosis[6]
  • Receiving other vaccines in the by 4 weeks[half dozen]
  • Moderate or severe illness. Still, balmy affliction (e.g., common cold) is usually not contraindicated.[6]

History [edit]

Cases of measles and deaths per 100000, per twelvemonth, in the United states of america over the 20th century

John Franklin Enders, who had shared the 1954 Nobel Prize in Medicine for piece of work on the polio virus, sent Thomas C. Peebles to Fay School in Massachusetts, where an outbreak of measles was underway; Peebles was able to isolate the virus from blood samples and throat swabs, and was later able to cultivate the virus and show that the affliction could be passed on to monkeys inoculated with the material he had collected.[23] Enders was able to utilise the cultivated virus to develop a measles vaccine in 1963 by attenuation through cultured craven embryo fibroblasts of the material isolated by Peebles.[40] [41]

In the late 1950s and early 1960s, well-nigh twice equally many children died from measles as from polio.[42] The vaccine Enders developed was based on the Edmonston strain of attenuated live measles virus, which was named for xi-yr-former David Edmonston, the Fay student from whom Peebles had taken the civilisation that led to the virus's cultivation.[43]

In the mid-20th century, measles was particularly devastating in Westward Africa, where child mortality rates were 50 percent earlier age v, and the children were struck with the blazon of rash and other symptoms mutual prior to 1900 in England and other countries. The first trial of a live attenuated measles vaccine was undertaken in 1960 past the British paediatrician David Morley in a village near Ilesha, Nigeria; in example he could exist accused of exploiting the Nigerian population, Morley included his own 4 children in the study. The encouraging results led to a second study of about 450 children in the village and at the Wesley Guild Hospital in Ilesha.

Following some other epidemic, a larger trial was undertaken in September and Oct 1962, in New York Metropolis with the assistance of the WHO: 131 children received the live Enders-adulterate Edmonston B strain plus gamma globulin, 130 children received a "further adulterate" vaccine without gamma globulin, and 173 children acted as control subjects for both groups. Every bit also shown in the Nigerian trial, the trial confirmed that the "further attenuated" vaccine was superior to the Edmonston B vaccine, and caused significantly fewer instances of fever and diarrhea. 2,000 children in the area were vaccinated with the further-attenuated vaccine.[44] [45]

Maurice Hilleman at Merck & Co., a pioneer in the development of vaccinations, developed an improved version of the measles vaccine in 1968 and subsequently the MMR vaccine in 1971, which vaccinates confronting measles, mumps and rubella in a unmarried shot followed by a booster.[9] [24] [46] One form is called "Attenuvax".[47] The measles component of the MMR vaccine uses Attenuvax,[48] which is grown in a chick embryo cell culture using the Enders' attenuated Edmonston strain.[48] Following ACIP recommendations, Merck decided not to resume production of Attenuvax every bit standalone vaccine on 21 October 2009.[49]

Types [edit]

Mumps, measles and rubella combined vaccine (MMR vaccine)

Measles is seldom given as an individual vaccine and is often given in combination with rubella, mumps, or varicella (chickenpox) vaccines.[1] Beneath is the list of measles-containing vaccines:

  • Measles vaccine (standalone vaccine)
  • Measles and rubella combined vaccine (MR vaccine)
  • Mumps, measles and rubella combined vaccine (MMR vaccine)[48] [50] [51]
  • Mumps, measles, rubella and varicella combined vaccine (MMRV vaccine)[5]

Club and culture [edit]

Most health insurance plans in the United states embrace the cost of vaccines, and Vaccines for Children Program may be able to aid those who do not have coverage.[52] State police requires vaccinations for school children, but offer exemptions for medical reasons and sometimes for religious or philosophical reasons.[53] All l states require 2 doses of the MMR vaccine at the advisable age.[54]

References [edit]

  1. ^ a b c d east f grand h i j k 50 m northward o p q r south t u v World Health Organization (April 2017). "Measles vaccines: WHO position paper – April 2017" (PDF). Weekly Epidemiological Tape. 92 (17): 205–27. hdl:10665/255377. PMID 28459148. Lay summary (PDF).
  2. ^ a b c "About Measles Vaccination | Vaccination and Immunizations | CDC". www.cdc.gov. 9 January 2020. Archived from the original on 27 April 2020. Retrieved 30 Apr 2020.
  3. ^ a b CDC (2 Baronial 2019). "Measles and the Vaccine (Shot)". Centers for Illness Control and Prevention. Archived from the original on 29 Jan 2020. Retrieved 30 April 2020.
  4. ^ Mitchell D (2013). The essential guide to children's vaccines. New York: St. Martin'southward Printing. p. 127. ISBN9781466827509. Archived from the original on 8 September 2017.
  5. ^ a b "ProQuad- measles, mumps, rubella and varicella virus vaccine live injection, powder, lyophilized, for pause". DailyMed. 26 September 2019. Archived from the original on 6 April 2020. Retrieved 29 January 2020.
  6. ^ a b c d e f thousand h i "MMR Vaccination | What You Should Know | Measles, Mumps, Rubella | CDC". www.cdc.gov. 24 December 2019. Archived from the original on 26 April 2020. Retrieved 30 Apr 2020.
  7. ^ "Data Canvas Observed Rate of Vaccine Reactions" (PDF). Globe Health Arrangement (WHO). Archived (PDF) from the original on nineteen Dec 2019. Retrieved 1 December 2018.
  8. ^ a b Centers for Illness Control and Prevention (2014). CDC health information for international travel 2014 the xanthous volume. p. 250. ISBN9780199948505. Archived from the original on 8 September 2017.
  9. ^ a b c CDC (5 November 2020). "History of Measles". Centers for Illness Command and Prevention . Retrieved 9 February 2021.
  10. ^ a b "Measles History". U.S. Centers for Affliction Control and Prevention (CDC). 5 February 2018. Archived from the original on vi Apr 2020. Retrieved 28 January 2020. Public Domain This article incorporates text from this source, which is in the public domain .
  11. ^ "Measles Fact canvass Northward°286". World Health Organization (WHO). November 2014. Archived from the original on iii Feb 2015. Retrieved 4 February 2015.
  12. ^ "Immunization coverage". World Health Organisation (WHO). Archived from the original on 13 July 2017. Retrieved 12 July 2017.
  13. ^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st listing 2019. Geneva: World Health Arrangement. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC By-NC-SA 3.0 IGO.
  14. ^ Abramson B (2018). Vaccine, vaccination, and immunization law. Bloomberg Law. pp. 10–30. ISBN9781682675830.
  15. ^ Babbott FL, Gordon JE (September 1954). "Mod measles". The American Journal of the Medical Sciences. 228 (three): 334–61. doi:10.1097/00000441-195409000-00013. PMID 13197385.
  16. ^ "Measles Prevention: Recommendations of the Immunization Practices Informational Committee (ACIP)". www.cdc.gov. Archived from the original on 15 May 2012. Retrieved 27 Apr 2020.
  17. ^ Centers for Illness Control and Prevention (CDC) (1994). "Summary of notifiable diseases, United states, 1993". MMWR. Morbidity and Mortality Weekly Report. 42 (53): i–xvii, 1–73. PMID 9247368. Archived from the original on 9 March 2010.
  18. ^ Centers for Disease Control and Prevention (CDC) (July 2007). "Summary of notifiable diseases, The states, 2007". MMWR. Morbidity and Mortality Weekly Report. 56 (53): 1–94. Archived from the original on 13 June 2018. Retrieved 10 September 2017.
  19. ^ Wallace G, Leroy Z (2015). "Measles". In Hamborsky J, Kroger A, Wolfe S (eds.). Epidemiology and Prevention of Vaccine-Preventable Diseases (13th ed.). Washington D.C.: Public Wellness Foundation. Archived from the original on 7 Feb 2015. Retrieved xxx April 2019.
  20. ^ "Measles Cases and Outbreaks". Archived from the original on 13 Feb 2015. Retrieved 30 Nov 2018.
  21. ^ Bloch AB, Orenstein WA, Stetler HC, Wassilak SG, Amler RW, Bart KJ, Kirby CD, Hinman AR (October 1985). "Health impact of measles vaccination in the United States". Pediatrics. 76 (4): 524–32. doi:ten.1542/peds.76.4.524. PMID 3931045. S2CID 6512947.
  22. ^ Centers for Affliction Control and Prevention (CDC) (March 2006). "Progress in reducing global measles deaths, 1999-2004". MMWR. Morbidity and Mortality Weekly Report. 55 (9): 247–nine. PMID 16528234. Archived from the original on xvi October 2007.
  23. ^ a b Martin D (4 Baronial 2010). "Dr. Thomas C. Peebles, Who Identified Measles Virus, Dies at 89". The New York Times. Archived from the original on 6 April 2020. Retrieved eleven February 2017.
  24. ^ a b Collins H (xxx August 1999). "The Man Who Saved Your Life - Maurice R. Hilleman - Developer of Vaccines for Mumps and Pandemic Flu". The Philadelphia Inquirer. Archived from the original on 6 March 2009. Retrieved 28 Jan 2020.
  25. ^ a b c d Parker AA, Staggs Due west, Dayan GH, Ortega-Sánchez IR, Rota PA, Lowe L, Boardman P, Teclaw R, Graves C, LeBaron CW (August 2006). "Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States". The New England Journal of Medicine. 355 (v): 447–55. doi:10.1056/NEJMoa060775. PMID 16885548.
  26. ^ Centers for Affliction Control and Prevention (CDC) (December 2006). "Measles--United States, 2005". MMWR. Morbidity and Mortality Weekly Report. 55 (l): 1348–51. PMID 17183226. Archived from the original on 13 March 2015.
  27. ^ Sankoh O, Welaga P, Debpuur C, Zandoh C, Gyaase S, Poma MA, Mutua MK, Hanifi SM, Martins C, Nebie Eastward, Kagoné M, Emina JB, Aaby P (June 2014). "The non-specific furnishings of vaccines and other babyhood interventions: the contribution of INDEPTH Health and Demographic Surveillance Systems". International Journal of Epidemiology. 43 (3): 645–53. doi:x.1093/ije/dyu101. PMC4052142. PMID 24920644.
  28. ^ "Vaccine (Shot) for Measles". Centers for Disease Command and Prevention (CDC). 2 August 2019. Archived from the original on 29 January 2020. Retrieved 29 January 2020. Public Domain This article incorporates text from this source, which is in the public domain .
  29. ^ a b "Birth-18 Years Immunization Schedule". Centers for Disease Control and Prevention (CDC). five February 2019. Archived from the original on half-dozen March 2016. Retrieved 29 January 2020. Public Domain This commodity incorporates text from this source, which is in the public domain .
  30. ^ "Measles". National Health Service UK. 20 October 2017. Archived from the original on 8 March 2019. Retrieved xi March 2019.
  31. ^ "MMR vaccine overview". National Health Service Britain. 8 Oct 2019. Archived from the original on 31 January 2013. Retrieved 29 January 2020.
  32. ^ "Measles vaccine: Canadian immunization guide". Public Health Agency of Canada. xviii July 2007. Archived from the original on 17 March 2019. Retrieved 13 March 2019.
  33. ^ "Information Sheet: Observed Rate of Vaccine Reactions: Measles, Mumps and Rubella Vaccines" (PDF). Globe Health Organization (WHO). May 2014. Archived (PDF) from the original on 17 December 2019. Retrieved i December 2018.
  34. ^ a b Di Pietrantonj, Carlo; Rivetti, Alessandro; Marchione, Pasquale; Debalini, Maria Grazia; Demicheli, Vittorio (20 April 2020). "Vaccines for measles, mumps, rubella, and varicella in children". The Cochrane Database of Systematic Reviews. 4: CD004407. doi:10.1002/14651858.CD004407.pub4. ISSN 1469-493X. PMC7169657. PMID 32309885.
  35. ^ Committee to Review Adverse Effects of Vaccines; Found Of, Medicine; Stratton, K.; Ford, A.; Rusch, Eastward.; Clayton, East. W. (9 April 2012). "Measles, Mumps, and Rubella Vaccine". Adverse Effects of Vaccines: Evidence and Causality. Washington, D.C.: The National Academies Press. doi:10.17226/13164. ISBN978-0-309-21436-0. PMID 24624471. Archived from the original on 7 November 2017. Retrieved 3 November 2017.
  36. ^ "Measles, mumps, and rubella (MMR) vaccine". Centers for Illness Control and Prevention. 22 August 2008. Archived from the original on viii October 2008. Retrieved 21 December 2008.
  37. ^ Institute of Medicine (US) Immunization Safety Review Committee (17 May 2004). Immunization Safety Review: Vaccines and Autism. Institute of Medicine of the National Academy of Sciences. doi:ten.17226/10997. ISBN978-0-309-09237-1. PMID 20669467. Archived from the original on vii Oct 2014. Retrieved 19 October 2019.
  38. ^ "Guidelines for Vaccinating Pregnant Women". Centers for Disease Control and Prevention. August 2016. Archived from the original on half dozen April 2020. Retrieved xxx April 2019.
  39. ^ "Contraindications and Precautions". Vaccine Recommendations and Guidelines of the ACIP. Centers for Disease Control and Prevention. 23 April 2020. Archived from the original on 1 May 2019. Retrieved thirty April 2019.
  40. ^ "Work by Enders Brings Measles Vaccine License". The Hartford Courant. 22 March 1963. Archived from the original on iii November 2012. A strain of measles virus isolated in 1954 by Dr. Thomas C. Peebles, instructor in pediatrics at Harvard, and Enders, formed the basis for the development of the nowadays vaccine
  41. ^ Griffin DE (March 2018). "Measles Vaccine". Viral Immunol. 31 (2): 86–95. doi:10.1089/vim.2017.0143. PMC5863094. PMID 29256824.
  42. ^ "The Measles Vaccine". The New York Times. 28 March 1963. Archived from the original on 30 April 2019. Retrieved thirty April 2019.
  43. ^ Hilleman MR (July 1992). "Past, nowadays, and future of measles, mumps, and rubella virus vaccines". Pediatrics. xc (1 Pt two): 149–53. doi:10.1542/peds.90.one.149. PMID 1603640. S2CID 33115842.
  44. ^ Morley DC, Woodland M, Krugman S, Friedman H, Grab B (1964). "Measles and Measles Vaccination in an African Village". Bulletin of the World Health Arrangement. 30: 733–ix. PMC2554995. PMID 14196817.
  45. ^ Pritchard J (thirteen November 1997). "Obituary: Dr C. A. Pearson". The Contained. Archived from the original on 24 Feb 2014. Retrieved 29 January 2014.
  46. ^ Sullivan P (13 April 2005). "Maurice R. Hilleman Dies; Created Vaccines (washingtonpost.com)". The Washington Post. Archived from the original on xx October 2012. Retrieved 21 July 2009.
  47. ^ Ovsyannikova IG, Johnson KL, Naylor S, Poland GA (February 2005). "Identification of HLA-DRB1-bound self-peptides following measles virus infection". Journal of Immunological Methods. 297 (1–2): 153–67. doi:10.1016/j.jim.2004.12.020. PMID 15777939.
  48. ^ a b c "G-1000-R Ii- measles, mumps, and rubella virus vaccine alive injection, powder, lyophilized, for intermission". DailyMed. 24 September 2019. Archived from the original on 6 April 2020. Retrieved 29 January 2020.
  49. ^ "Q&Every bit near Monovalent 1000-1000-R Vaccines". Centers for Affliction Control and Prevention (CDC). 26 October 2009. Archived from the original on nineteen October 2019. Retrieved xviii October 2019.
  50. ^ "M-M-RVaxPro EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 6 April 2020. Retrieved 29 January 2020.
  51. ^ "Priorix - Summary of Product Characteristics (SmPC)". (emc). 14 January 2020. Archived from the original on 6 April 2020. Retrieved 29 January 2020.
  52. ^ "VFC | Dwelling | Vaccines for Children Program | CDC". world wide web.cdc.gov. 2 April 2019. Archived from the original on 1 May 2020. Retrieved 30 Apr 2020.
  53. ^ "State Vaccination Requirements | CDC". world wide web.cdc.gov. xi March 2019. Archived from the original on 2 April 2020. Retrieved thirty April 2020.
  54. ^ "MMR Vaccine Mandates for Child Care and Thou-12". www.immunize.org. Archived from the original on 12 June 2020. Retrieved 30 Apr 2020.

Farther reading [edit]

  • World Wellness Organisation (2009). The immunological basis for immunization series : module 7: measles - Update 2009. Geneva, Switzerland: World Wellness System (WHO). hdl:10665/44038. ISBN9789241597555.
  • Ramsay 1000, ed. (2019). "Chapter 21: Measles". Immunisation against communicable diseases. London, England: Public Health England.
  • Wallace 1000, Leroy Z (2015). "Chapter 13: Measles". In Hamborsky J, Kroger A, Wolfe S (eds.). Epidemiology and Prevention of Vaccine-Preventable Diseases (13th ed.). Washington D.C.: U.S. Centers for Disease Control and Prevention (CDC). ISBN978-0990449119.
  • Gastanaduy PA, Redd SB, Clemmons NS, et al. (2019). "Affiliate 7: Measles". In Roush SW, Baldy LM, Hall MH (eds.). Manual for the surveillance of vaccine-preventable diseases. Atlanta, Georgia: U.S. Centers for Disease Control and Prevention (CDC).

External links [edit]

  • "MMR (Measles, Mumps, & Rubella) Vaccine Information Statement". U.S. Centers for Affliction Control and Prevention (CDC). 22 October 2019.
  • "MMRV (Measles, Mumps, Rubella & Varicella) Vaccine Information Statement". U.S. Centers for Disease Command and Prevention (CDC). 22 October 2019.
  • Measles Vaccine at the United states National Library of Medicine Medical Subject Headings (MeSH)
  • "Measles Vaccine". Drug Information Portal. U.Due south. National Library of Medicine.

colemanforgand.blogspot.com

Source: https://en.wikipedia.org/wiki/Measles_vaccine

0 Response to "If I Was Immunized in the 60 for Measles Can I Catch Them Again"

Postar um comentário

Assinar: Postar comentários (Atom)

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel